MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

25 May 2024 Evaluate
The Sales for the quarter ended March 2024 of Rs. 7.79 million declined by -7890.00% from Rs. -0.10 millions.The Total Profit for the quarter ended March 2024 of Rs. 7.41 millions grew from Rs.-1.97 millions Operating profit Margin for the quarter ended March 2024 improved to 7.41% as compared to -1.97% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 7.79 -0.10 -7890.00 23.82 9.13 160.90 23.82 9.13 160.90
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 7.41 -1.97 -476.14 19.31 4.56 323.46 19.31 4.56 323.46
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 7.41 -1.97 -476.14 19.31 4.56 323.46 19.31 4.56 323.46
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 7.41 -1.97 -476.14 19.31 4.56 323.46 19.31 4.56 323.46
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 7.41 -1.97 -476.14 19.31 4.56 323.46 19.31 4.56 323.46
Equity 652.60 652.60 0.00 652.60 652.60 0.00 652.60 652.60 0.00
PBIDTM(%) 95.12 1970.00 -95.17 81.07 49.95 62.31 81.07 49.95 62.31
Peers
Company Name CMP
Redington 392.20
Amrapali Industries 37.05
Adani Enterprises 3100.00
Rashi Peripheral 805.00
PDS 348.90
View more..